4.8 (173) In stock
Brought to you by Merck & Co, Inc., Rahway, NJ, USA (known as MSD outside the US and Canada) —dedicated to using leading-edge science to save and improve lives around the world. Learn more about the Merck Manuals and our commitment to Global Medical Knowledge.
Evaluation of Breast Disorders - Gynecology and Obstetrics - Merck Manuals Professional Edition
HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer - Modern Pathology
Neoadjuvant immunotherapy and chemotherapy regimens for the treatment of high-risk, early-stage triple-negative breast cancer: a systematic review and network meta-analysis, BMC Cancer
OPBC
Prognostic and predictive impact of gene expression in node‐positive early breast cancer patients receiving dose‐dense versus standard‐dose adjuvant chemotherapy - Reinisch - 2023 - Molecular Oncology - Wiley Online Library
Cancers, Free Full-Text
Breast Imaging Devices Market Size, Share, Growth Drivers 2033
Nipple Discharge: Causes, Symptoms, and Treatment
PDF) Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries
Breast Masses (Breast Lumps) - Gynecology and Obstetrics - Merck Manuals Professional Edition
